News

Are Prescription Drug Monitoring Programs (PDMPs) Sufficient to Lead Us out of the Opioid Crisis?

Although the adoption of PDMPs is an effort that holds promise, their ability to stem opioid overprescribing is inherently limited by the specific form of misuse that the programs aim to address. Read more in this insightful Brookings Op-Ed here.

How Predictive Analytics Can be Used to Prevent Opioid Overdoses

The devastation of the nation’s opioid epidemic does not need further explanation. Seemingly every day, news stories underscore the fact that opioid overdose knows no gender, race or class boundaries. Too few of these stories, however, speak of available solutions to combat this epidemic. Read the full article by Mark […]

Venebio CMO’s Op-Ed on White House Opioid Panel Published in the Philadelphia Inquirer

Venebio’s Chief Medical Officer, Barb Zedler, M.D., penned an opinion piece in response to an interim report from President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis, which was published in the Philadelphia Inquirer. Read the piece here.

VOA Feature: Firm’s Tool Assesses Risks for Opioid Overdoses

Venebio Opioid Advisor and Venebio’s efforts to address the opioid overdose epidemic were featured in Virginia Business magazine. Read the article here.

Venebio Group at Health 2.0 Fall Conference

Venebio Group will present at the upcoming Health 2.0 Annual Fall Conference in Santa Clara, CA on October 2, 2017. During the presentation, Mr. Mark Tripodi, Venebio’s Chief Development Officer, will highlight the Venebio Opioid Advisor clinical decision support tool and its benefits toward safer opioid prescribing.

Second Health Plan to Implement Venebio’s Opioid Overdose Risk-Screening Tool

RICHMOND, Va. (September 22, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that Amida Care, a New York-based health plan provider, has implemented Venebio Opioid Advisor™ (VOA™), the company’s risk-screening tool for prescription opioid overdose. Amida Care is the second health plan to use VOA following […]

White Paper: Predictive Analytics Can Help Reduce Prescription Opioid Overdoses and Health Care Costs

A recently published white paper, “Predictive Analytics Can Help Reduce Prescription Opioid Overdoses and Health Care Costs,” projected VOA to help reduce the incidence of prescription opioid overdose by 15 percent, leading to: 500 fewer prescription opioid overdoses, 400 fewer emergency department visits, 120 fewer hospitalizations, and saving more than […]

How Health IT Tools are Working to Reduce the Prescription Opioid Epidemic

Many healthcare provider and payer organizations are looking to leverage advanced health IT tools, such as data analytics and predictive modeling, to identify risk factors that can put patients at high risk for a prescription opioid overdose or addiction in order to intervene before an adverse event occurs. Read the […]

Venebio Launches Tool to Help Reduce Opioid Overdoses: Initial adopters of Venebio Opioid Advisor include health plans and Medicaid-managed care plans in Virginia and New York

Venebio Group, a leader in personalized risk prediction algorithms, today announced that its risk-screening tool for opioid overdose, Venebio Opioid Advisor™ (VOA™), is now commercially available nationwide following the conclusion of its pilot phase. While much of the national attention around the opioid epidemic has focused on addiction, many unintentional […]

Study of U.S. Opioid Users Shows Venebio’s Overdose Risk Index to Have 90% Accuracy

A recent study published in Pain Medicine validates the strong performance of Venebio Group’s risk index tool — Venebio Opioid Advisor (VOA) — at predicting the likelihood of a life-threatening overdose in patients taking a prescription opioid. Prescription opioid sales quadrupled in the United States between 1999 and 2010 [1], […]